Using KDM4A knockdown iPSCs, we test whether impaired H3K9me3 clearance disrupts endocrine specification and β-cell maturation, offering insights into the epigenetic barriers that limit the generation of functional cells for diabetes therapy. The gene discussed is KDM4A; the disease is diabetes mellitus.